TGTX

54.29

1.25% 0.67

Dopo l'orario di chiusura: 54.00 -0.29 -0.53%

Tg Therapeutics Inc (TGTX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché TGTX Giù? Forum Previsione Frazionamento azionario

Precedente Chiudi:

$53.62

Aprire:

$54.17

Volume 24 ore:

1.66M

Relative Volume:

0.81

Capitalizzazione di mercato:

$8.31B

Reddito:

$700.35M

Utile/perdita netta:

$461.90M

Rapporto P/E:

18.92

EPS:

2.8696

Flusso di cassa netto:

$-14.19M

1 W Prestazione:

-5.47%

1M Prestazione:

-4.59%

6M Prestazione:

+61.91%

1 anno Prestazione:

+48.09%

Intervallo 1D:

$53.15

$54.98

Intervallo di 1 settimana:

$53.15

$57.66

Portata 52W:

$26.76

$59.30

Tg Therapeutics Inc Stock (TGTX) Company Profile

Nome

Tg Therapeutics Inc

Settore

Healthcare (1064)

Industria

Biotechnology (595)

Telefono

(212) 554-4484

Indirizzo

2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY

Dipendente

399

Cinguettio

@TGTherapeutics

Prossima data di guadagno

2026-11-02

Ultimi documenti SEC

TGTX's Discussions on Twitter

Compare TGTX vs VRTX, MRNA, REGN, ARGX, RVMD

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
TGTX Tg Therapeutics Inc	54.29	8.79B	700.35M	461.90M	-14.19M	2.8696
VRTX Vertex Pharmaceuticals Inc	504.73	133.37B	12.34B	4.34B	3.71B	16.87
MRNA Moderna Inc	190.01	79.40B	2.23B	-3.19B	-1.60B	-8.1462
REGN Regeneron Pharmaceuticals Inc	735.20	81.13B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	919.21	60.03B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	206.64	43.93B	742.00K	-1.37B	-1.07B	-7.0731

Tg Therapeutics Inc Stock (TGTX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-10-06	Ripresa	H.C. Wainwright	Buy
2025-07-10	Ripresa	Goldman	Neutral
2024-10-29	Iniziato	TD Cowen	Buy
2023-08-02	Aggiornamento	Goldman	Sell → Neutral
2023-06-26	Ripresa	Jefferies	Buy
2022-05-20	Iniziato	BofA Securities	Underperform
2022-02-23	Reiterato	B. Riley Securities	Buy
2021-11-15	Downgrade	Goldman	Neutral → Sell
2021-04-20	Iniziato	Goldman	Neutral
2021-04-19	Reiterato	H.C. Wainwright	Buy
2020-09-01	Iniziato	JP Morgan	Overweight
2020-08-11	Reiterato	H.C. Wainwright	Buy
2020-06-05	Iniziato	Evercore ISI	Outperform
2020-01-17	Reiterato	H.C. Wainwright	Buy
2019-11-27	Ripresa	B. Riley FBR	Buy
2019-02-06	Ripresa	Jefferies	Buy
2018-09-25	Downgrade	Raymond James	Strong Buy → Outperform
2018-03-09	Reiterato	B. Riley FBR, Inc.	Buy
2017-12-01	Ripresa	B. Riley FBR, Inc.	Buy
2017-11-14	Ripresa	H.C. Wainwright	Buy
2017-04-25	Iniziato	Jefferies	Buy
2017-03-06	Reiterato	FBR & Co.	Outperform
2016-10-06	Ripresa	Brean Capital	Buy
2016-05-27	Iniziato	SunTrust	Buy
2015-12-01	Iniziato	FBR Capital	Outperform
2015-09-09	Iniziato	Raymond James	Strong Buy
2015-08-12	Ripresa	H.C. Wainwright	Buy
2015-06-19	Reiterato	Brean Capital	Buy
2014-12-11	Reiterato	ROTH Capital	Buy
2014-12-10	Reiterato	ROTH Capital	Buy

Mostra tutto

Tg Therapeutics Inc Borsa (TGTX) Ultime notizie

Oct 01, 2026

After tax other income/expense of TG Therapeutics, Inc. – HAN:NKB2 - TradingView

Sep 29, 2026

TG Therapeutics, Inc. Revenue Breakdown – HAN:NKB2 - TradingView

Sep 29, 2026

NKB2 Forecast — Price Target — Prediction for 2027 - TradingView

Sep 29, 2026

Sep 28, 2026

Investigation launched into TG Therapeutics' of... - Pluang

Sep 28, 2026

Kuehn Law Encourages Investors of TG Therapeutics, Inc. to Contact Law Firm - Morningstar

Sep 28, 2026

Sep 26, 2026

TGTX Stock Rises On Wall Street Price Target Hike, New Schizophrenia Trial Launch - Stocktwits

Sep 26, 2026

Sep 25, 2026